Overall, these results indicate a high inflammatory signature in DLBCL and a tight link between the expression of CD68 (macrophage marker) and of pro-inflammatory molecules in the DLBCL microenvironment. The gene discussed is CD68; the disease is diffuse large B-cell lymphoma.